SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

PIEZO1 mechanical insensitivity in generalized lymphatic dysplasia with the potential for pharmacological rescue

Ludlow, MJ; Povstyan, OV; Linley, DM; Martin-Almedina, S; Revill, C; Cuthbertson, K; Smith, KA; Fay, E; Fotiou, E; Bush, A; et al. Ludlow, MJ; Povstyan, OV; Linley, DM; Martin-Almedina, S; Revill, C; Cuthbertson, K; Smith, KA; Fay, E; Fotiou, E; Bush, A; Hogg, C; Linden, T; Tan, NB; White, SM; Del Rey Jimenez, JC; Sackey, E; Dempsey, E; Mansour, S; Parsonage, G; Kalli, AC; Foster, R; Ostergaard, P; Beech, DJ (2025) PIEZO1 mechanical insensitivity in generalized lymphatic dysplasia with the potential for pharmacological rescue. iScience, 28 (8). p. 113110. ISSN 2589-0042
SGUL Authors: Ostergaard, Pia

[img] PDF Published Version
Available under License Creative Commons Attribution.

Download (4MB)
[img] PDF (Document S1. Figures S1–S9 and Tables S1 and S2.) Supporting information
Download (1MB)
[img] Microsoft Excel (Data S1. Original data for laboratory results.) Supporting information
Download (5MB)
[img] PDF Accepted Version
Available under License Creative Commons Attribution.

Download (2MB)

Abstract

PIEZO1 variants have been associated with generalized lymphatic dysplasia (GLD) through mechanisms involving reduced PIEZO1 expression. Here, we report variants where the mechanism involves reduced channel mechanical sensitivity. Two of the variants encode amino acid changes in the channel’s cap structure (Ile2270Thr and Arg2335Gln), one in the ninth transmembrane helical unit (THU) below the cap (Gly1978Asp) and one in the fifth THU distant from the cap (Glu829Val). Patch-clamp studies of the cap and sub-cap variant channels revealed abolished or reduced channel mechanical sensitivity with the possibility to activate the channels and partly rescue mechanical sensitivity by the small molecule Yoda1. The potency of Yoda1 at the variant channels was less than at the wild-type channel but chemical synthesis of Yoda1 analogues revealed a molecule with improved potency. The data suggest cases of GLD in which there is decreased channel mechanical sensitivity and the potential to reduce dysfunction pharmacologically.

Item Type: Article
Additional Information: © 2025 The Author(s). Published by Elsevier Inc. Under a Creative Commons license (http://creativecommons.org/licenses/by/4.0/)
SGUL Research Institute / Research Centre: Academic Structure > Cardiovascular & Genomics Research Institute
Academic Structure > Cardiovascular & Genomics Research Institute > Genomics
Journal or Publication Title: iScience
ISSN: 2589-0042
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
110044/Z/15/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
RG/17/11/33042British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
SP/13/5/30288British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
MR/P011543/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
RG/17/7/33217British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
12-13/01Newlife Foundation for Disabled Childrenhttp://dx.doi.org/10.13039/501100000871
UNSPECIFIEDUniversity Of Leedshttp://dx.doi.org/10.13039/501100000777
FS/4yPhD/F/20/34130British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
FS/18/78/33932British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
NIHR203331National Institute for Health and Care Research (NIHR) Leeds Biomedical Research CentreUNSPECIFIED
URI: https://openaccess.sgul.ac.uk/id/eprint/117689

Actions (login required)

Edit Item Edit Item